Affiliations 

  • 1 School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia
  • 2 Touro University California College of Pharmacy, Vallejo, CA, United States
  • 3 Departamento de Ciências da Saúde, Ambiente e Tecnologias, Universidade de Santiago, Assomada, Cabo Verde
  • 4 School of Pharmacy, Nanjing Medical University, Nanjing, China
  • 5 Department of Pharmacy, University of Split School of Medicine, Split, Croatia
  • 6 School of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon
  • 7 School of Pharmacy, Lebanese International University, Beirut, Lebanon
  • 8 Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Cawangan Selangor, Selangor, Malaysia
  • 9 Universidade de Lisboa, Faculdade de Farmácia, Departamento de Farmácia Farmacologia e Tecnologias em Saúde, Lisboa, Portugal
  • 10 Pharmacy Department, School of Allied Health Sciences, San Pedro College, Davao City, Philippines
  • 11 Institute of Pharmacy, University of Makati, Makati City, Philippines
  • 12 School of Pharmacy, Emilio Aguinaldo College, Cavite City, Philippines
  • 13 Clinical and Hospital Pharmacy Department, College of Pharmacy, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
  • 14 Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
  • 15 State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China
Front Pharmacol, 2023;14:1215475.
PMID: 37654614 DOI: 10.3389/fphar.2023.1215475

Abstract

Introduction: An estimated 80% of the world's population use traditional and complementary medicine (T&CM) products as part of their healthcare, with many accessed through pharmacy. This cross-cultural study posed a set of professional practice responsibilities and actions to pharmacists related to T&CM products, with a view toward developing consensus, safeguarding, and promoting the health of the public. Methods: Data were collected from 2,810 pharmacists across nine countries during 2022 via a cross-sectional online survey reported in accordance with the guidelines of STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) and the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). Results: Of the 2,810 participants from nine countries, 2,341 completed all sections of the survey. Of these, most agreed (69%) that T&CM product use was common in the community they served, but most did not have adequate training to support consumer needs. Over 75% acknowledged that there were known and unknown safety risks associated with T&CM use. Of 18 professional responsibilities posed, 92% agreed that pharmacists should be able to inform consumers about potential risks, including T&CM side effects and drug-herb interactions. The provision of accurate scientific information on the effectiveness of T&CM products, skills to guide consumers in making informed decisions, and communication with other healthcare professionals to support appropriate and safe T&CM product use were all ranked with high levels of agreement. In order to effectively fulfill these responsibilities, pharmacists agreed that regulatory reforms, development of T&CM education and training, and access to quality products supported by high-quality evidence were needed. Conclusion: General agreement from across nine countries on eighteen professional responsibilities and several stakeholder actions serve as a foundation for the discussion and development of international T&CM guidelines for pharmacists.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.